FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $40,000 | -51.8% | 10,701 | -53.8% | 0.00% | -60.0% |
| Q4 2018 | $83,000 | -20.2% | 23,172 | +14.0% | 0.01% | +25.0% |
| Q1 2018 | $104,000 | +23.8% | 20,321 | +11.0% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | -3.4% | 18,308 | +36.2% | 0.00% | 0.0% |
| Q1 2016 | $87,000 | -65.5% | 13,440 | -56.8% | 0.00% | -66.7% |
| Q4 2015 | $252,000 | -34.0% | 31,140 | -16.6% | 0.01% | -7.7% |
| Q2 2015 | $382,000 | +210.6% | 37,339 | +180.1% | 0.01% | +225.0% |
| Q1 2015 | $123,000 | +26.8% | 13,331 | -4.1% | 0.00% | 0.0% |
| Q4 2014 | $97,000 | – | 13,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |